MedPage Today) -- A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results from the KEYNOTE-A18 trial...
The Center For Mind & Esteem Development, Inc. A Course In Personal & Professional Development LoveNow360 For Self, Community & World Engagement & Empowerment Marvin Mack, Founder & Creative Director lovenow360.net
410-971-6235
personaldevelopment@me.com
Copyright © 2023 lovenow360 for Self, Community & World Engagement & Empowerment
The Center For Mind & Esteem Development, Inc.. All Rights Reserved
